Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Lodoxamide tromethamine
Trade Name: Alomide Ophthalmic Solution
Date Designated: 10/16/1991
Orphan Designation: Treatment of vernal keratoconjunctivitis.
Orphan Designation Status: Designated/Approved
Alcon Laboratories, Inc.
6201 South Freeway
Fort Worth, Texas 76134
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Lodoxamide tromethamine
Trade Name: Alomide Ophthalmic Solution
Marketing Approval Date: 09/23/1993
Approved Labeled Indication: Treatment of ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis.
Exclusivity End Date: 09/23/2000 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-